JO2082B1 - The formed granules of clavulinite and excipients - Google Patents

The formed granules of clavulinite and excipients

Info

Publication number
JO2082B1
JO2082B1 JO19982082A JOP19982082A JO2082B1 JO 2082 B1 JO2082 B1 JO 2082B1 JO 19982082 A JO19982082 A JO 19982082A JO P19982082 A JOP19982082 A JO P19982082A JO 2082 B1 JO2082 B1 JO 2082B1
Authority
JO
Jordan
Prior art keywords
granules
clavulanate
excipients
employing
prepare
Prior art date
Application number
JO19982082A
Other languages
Arabic (ar)
English (en)
Inventor
ويليام جرويندال جان
Original Assignee
جيست بوكيدس بي. في.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by جيست بوكيدس بي. في. filed Critical جيست بوكيدس بي. في.
Application granted granted Critical
Publication of JO2082B1 publication Critical patent/JO2082B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JO19982082A 1997-11-17 1998-11-17 The formed granules of clavulinite and excipients JO2082B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97203576 1997-11-17

Publications (1)

Publication Number Publication Date
JO2082B1 true JO2082B1 (en) 2000-05-21

Family

ID=8228930

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19982082A JO2082B1 (en) 1997-11-17 1998-11-17 The formed granules of clavulinite and excipients

Country Status (13)

Country Link
EP (1) EP0973520A1 (fr)
JP (1) JP2001516365A (fr)
CN (1) CN1242705A (fr)
AU (1) AU1337999A (fr)
BR (1) BR9806280A (fr)
CA (1) CA2272402A1 (fr)
CO (1) CO4980893A1 (fr)
JO (1) JO2082B1 (fr)
NO (1) NO993467L (fr)
PL (1) PL334517A1 (fr)
TR (1) TR199901584T1 (fr)
WO (1) WO1999025343A1 (fr)
ZA (1) ZA9810499B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (fr) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
GB0031267D0 (en) * 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
AU2004234176B2 (en) * 2003-05-02 2010-05-13 Globopharm Pharmazeutische Produktions- Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
US8293272B2 (en) * 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
FI20080352A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
FI20080346A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi lisäaineita sisältävän tabletin valmistamiseksi
FI20080353A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi erittäin korkean lääkepitoisuuden tabletin valmistamiseksi
FI20070521A7 (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
FI20080355A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi metforminia käsittävien tablettien valmistamiseksi
CA2723409C (fr) 2008-05-09 2016-11-08 Atacama Labs Oy Procede et appareil de granulation par voie seche
CN104582692A (zh) * 2012-08-28 2015-04-29 中化帝斯曼制药有限公司荷兰公司 包含抗生素和β-内酰胺酶抑制剂的组合物，其中抗生素和β-内酰胺酶抑制剂中的至少一种是迷你片剂的形式
JP2014062064A (ja) * 2012-09-21 2014-04-10 Ohara Yakuhin Kogyo Kk バルサルタン含有錠剤の製造方法
JP6141472B2 (ja) * 2016-03-02 2017-06-07 大原薬品工業株式会社 バルサルタン含有錠剤の製造方法
KR20250026366A (ko) * 2017-07-05 2025-02-25 노파르티스 아게 신규한 약학적 조성물
CN110051637A (zh) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 阿莫西林克拉维酸钾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2251250C3 (de) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten
NZ187013A (en) * 1977-04-27 1985-04-30 Beecham Group Ltd 9-amino-9-deoxy-clavulanic acid derivatives and pharmaceutical compositions
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Also Published As

Publication number Publication date
AU1337999A (en) 1999-06-07
ZA9810499B (en) 1999-05-24
TR199901584T1 (xx) 2000-01-21
CO4980893A1 (es) 2000-11-27
PL334517A1 (en) 2000-02-28
WO1999025343A1 (fr) 1999-05-27
JP2001516365A (ja) 2001-09-25
EP0973520A1 (fr) 2000-01-26
NO993467D0 (no) 1999-07-14
BR9806280A (pt) 2000-02-15
CN1242705A (zh) 2000-01-26
CA2272402A1 (fr) 1999-05-27
NO993467L (no) 1999-07-14

Similar Documents

Publication Publication Date Title
JO2082B1 (en) The formed granules of clavulinite and excipients
AU3418993A (en) System for delivering an active substance for sustained release
AU5022593A (en) Prodrugs, their preparation and use as pharmaceuticals
AUPM969994A0 (en) Equine anthelmintic formulations
EG23826A (en) Pharmaceutical formulations
AU5087290A (en) Transmembrane formulations for drug administration
MX9704910A (es) Formula de liberacion controlada (albuterol).
AU4243289A (en) Pharmaceutical formulations
AP9600883A0 (en) Pharmaceutical formulations
AU6397694A (en) Smoke evacuator for smoke generating devices
AU4540396A (en) New stable ganelic formulations containing an acid-labile benzimidazol compound, and production process
AU5337796A (en) Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same
AU4595689A (en) Medicinal aerosol formulations
AU5358694A (en) Method and devices for delivering drugs by inhalation
AU9166591A (en) Method and apparatus for granulation
AU1811592A (en) Hemispherically wide-radiating-angle loudspeaker system
HU9301700D0 (en) Methods for producing biphenylic derivatives and pharmaceutical preparatives containing them as active substance
AU7929391A (en) New 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles and 1,2,3,4-tetrahydro-beta-carbolines processes for preparing these and pharmaceutical compositions containing them
AU7420494A (en) Rapamycin formulations for oral administration
IL112897A0 (en) Aerosol drug formulations containing vitamin e
AU1930097A (en) Slow-release pharmaceutical formulations containing mizolastin
GB9201639D0 (en) Pharmaceutical formulations
ZA96392B (en) Pharmaceutical formulations
AU5263596A (en) Pharmaceutical formulations of (rhizophora mangle l)
FI934823A0 (fi) Foerfarande foer framstaellning av nya, farmaceutiskt aktiva bens(e) indenderivat